Everolimus

Drug Details

Everolimus is a versatile medication primarily used to prevent organ rejection in kidney and liver transplants when used alongside other drugs like cyclosporine and tacrolimus. It belongs to the immunosuppressant class, which functions by weakening the immune system to help the body accept a new organ more easily. Additionally, Everolimus is marketed under the brand name Afinitor and is prescribed for treating various types of cancer, including hormone receptor-positive, HER2-negative breast cancer, neuroendocrine tumors, and renal cell cancer. It is also used to manage conditions associated with tuberous sclerosis complex, such as certain types of kidney and brain tumors, and seizures in specific age groups. As a kinase inhibitor, Everolimus works by blocking proteins involved in the growth and spread of cancer cells, thereby inhibiting tumor progression. This oral medication is typically taken once daily, but dosages may be adjusted based on regular blood tests to ensure safety and efficacy. Common side effects may include mouth sores and skin rashes. It’s essential to consult healthcare professionals for personalized medical advice before using Everolimus, as this summary is intended for educational purposes and does not replace professional guidance.